drugset / Trial / NCT03159559
PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is undertaken to determine if intravenous Lipo-PGE1 therapy would improve coronary microvascular perfusion in patients with ischemic heart disease by CMRI.
Timeline
- Start
- 2017-01
- Primary completion
- 2017-12
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprostadil | Unknown | 10 ug | Intravenous |